Common
05-25-2019, 04:49 AM
The one-time gene therapy developed by Novartis, Zolgensma, will cost $2.125 million
US regulators have approved the most expensive medicine ever, for a disorder that destroys a baby’s muscle control and kills nearly all of those with the most common variant of the disease within a couple years.
The treatment is priced at $2.125 million. Out-of-pocket costs for patients will vary based on insurance coverage.
The gene therapy, developed by Novartis, treats a rare condition called spinal muscular atrophy, which strikes about 400 babies born in the US each year.
The Food and Drug Administration on Friday approved the drug, called Zolgensma, for all children under age 2 who are confirmed by a genetic test to have any of the four types of the disease.
The therapy, a one-time infusion that takes about an hour, will be available within two weeks.
Novartis said it will let insurers make payments over five years, at $425,000 per year, and will give partial rebates if the drug doesn’t work.
https://nypost.com/2019/05/24/fda-approves-2m-medicine-most-expensive-ever/
US regulators have approved the most expensive medicine ever, for a disorder that destroys a baby’s muscle control and kills nearly all of those with the most common variant of the disease within a couple years.
The treatment is priced at $2.125 million. Out-of-pocket costs for patients will vary based on insurance coverage.
The gene therapy, developed by Novartis, treats a rare condition called spinal muscular atrophy, which strikes about 400 babies born in the US each year.
The Food and Drug Administration on Friday approved the drug, called Zolgensma, for all children under age 2 who are confirmed by a genetic test to have any of the four types of the disease.
The therapy, a one-time infusion that takes about an hour, will be available within two weeks.
Novartis said it will let insurers make payments over five years, at $425,000 per year, and will give partial rebates if the drug doesn’t work.
https://nypost.com/2019/05/24/fda-approves-2m-medicine-most-expensive-ever/